Caroline Huber, MPH

Rhythm Pharmaceuticals
Boston, United States

Disclosure information not submitted.

Presentation(s):

• SAT-703 - Real-Word Weight and Healthcare Utilization Outcomes with Setmelanotide in US Patients With Bardet-Biedl Syndrome

  Saturday, June 13, 2026
  9:30 AM - 4:30 PM CT

• SUN-724 - Transforming the Burden of Hyperphagia in Bardet-Biedl Syndrome: 6-Month Real-World Outcomes from the RESTORE Study

  Sunday, June 14, 2026
  9:00 AM - 4:00 PM CT